Despite the fact that the control sample used for the ALC + ACP samples was drawn from the same study as a subcohort of the AD controls, it displayed a higher frequency of the AD risk allele A (16.9%) than the corresponding control subcohort used for AD (13.9%). This evidence concerns the gene ALLC and Alzheimer disease.